Nonetheless, combining the total metabolic syndrome score with the AST/ALT ratio, a simple and reliable indicator of advanced fibrosis [27,31,32], offers significant potential to improve noninvasive assessment of fibrosis severity. The gene discussed is GPT; the disease is metabolic syndrome.